Latest Breaking News On - Michael dillen - Page 2 : comparemela.com

Oxurion Receives EUR 1 0 Million under Amended Atlas Funding Program Total of EUR 3 5 Million in Unconditional Funding Allowing Company to Reach Topline Data from KALAHARI Trial This Year

Oxurion Receives EUR 1 0 Million under Amended Atlas Funding Program Total of EUR 3 5 Million in Unconditional Funding Allowing Company to Reach Topline Data from KALAHARI Trial This Year
finanzen.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.ch Daily Mail and Mail on Sunday newspapers.

United statesRegion flamandeMichael dillenMaryt conwayTom graneyFunding programAtlas special opportunitiesConway communicationsCompany annualEuronext brusselsSubscription agreement

Oxurion NV: Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC

Oxurion NV: Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesRegion flamandeRheinland pfalzTom graneyMaryt conwayMichael dillenConway communicationsAtlas special opportunitiesCompany annualEuronext brusselsBelgian transparency

Oxurion Receives Transparency Notifications from Atlas Special Opportunities LLC

Regulated Information Leuven, BELGIUM, Boston, MA, US – October 30, 2023 – 8.00 AM CET Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company developing next generation standard of care ophthalmic therapies, with clinical stage assets in vascular retinal disorders, today announced that, pursuant to Belgian Transparency legislation1 it has received transparency notifications as follows: Oxurion received a first transparency notification on October 27, 2023, from Atlas Special Opportuni

Region flamandeUnited statesMichael dillenMaryt conwayTom graneyAtlas special opportunitiesConway communicationsCompany annualEuronext brusselsBelgian transparencyRetinal disordersIopharmaceutical companyAtlas special opportunitiesStandard of care

Oxurion NV: Oxurion Receives EUR 1 5 Million under Amended Atlas Funding Program; Total of EUR 3 5 Million in Unconditional Funding Allowing Company to Achieve Topline Data from KALAHARI Trial

Oxurion NV: Oxurion Receives EUR 1 5 Million under Amended Atlas Funding Program; Total of EUR 3 5 Million in Unconditional Funding Allowing Company to Achieve Topline Data from KALAHARI Trial
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Region flamandeUnited statesMaryt conwayIhre chancenTom graneyIndiens wirtschaftMichael dillenConway communicationsFunding programAtlas special opportunitiesCompany annualEuronext brusselsSubscription agreementDer indienDie highlights

Oxurion Receives EUR 1 5 Million under Amended Atlas Funding Program; Total of EUR 3 5 Million in Unconditional Funding Allowing Company to Achieve Topline Data from KALAHARI Trial

25.10.2023 - Leuven, BELGIUM, Boston, MA, US – October 25, 2023 – 8 am CET – Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company developing next-generation standard of care ophthalmic therapies, with clinical stage assets in vascular retinal .

United statesRegion flamandeTom graneyMichael dillenMaryt conwayConway communicationsCompany annualFunding programSubscription agreementEuronext brusselsOxurion chartXurion kursXurion aktie